Michael Montagne

911 total citations
59 papers, 596 citations indexed

About

Michael Montagne is a scholar working on Economics and Econometrics, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Montagne has authored 59 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Pharmacology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Montagne's work include Pharmaceutical industry and healthcare (9 papers), Pharmaceutical Economics and Policy (9 papers) and Psychedelics and Drug Studies (6 papers). Michael Montagne is often cited by papers focused on Pharmaceutical industry and healthcare (9 papers), Pharmaceutical Economics and Policy (9 papers) and Psychedelics and Drug Studies (6 papers). Michael Montagne collaborates with scholars based in United States, France and Finland. Michael Montagne's co-authors include William W. McCloskey, Henri Berthiaux, Cendrine Gatumel, Barry A Bleidt, David Scott, Carol B. Pugh, Rosa Rodríguez-Monguió, Enrique Seoane‐Vazquez, H. Peigue‐Lafeuille and D. Abiteboul and has published in prestigious journals such as SHILAP Revista de lepidopterología, Social Science & Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Michael Montagne

53 papers receiving 506 citations

Peers

Michael Montagne

GHP

PHARM

SPS

Alan Branthwaite United Kingdom

S G Elliott United States

Erin R. Holmes United States

Sandy Welsh Canada

Scott Monteith United States

Hyun-Jeong Park South Korea

David Dickinson South Africa

Gordon Becket New Zealand

Ashish Chandra United States

Gail Hughes South Africa

Alan Branthwaite United Kingdom

Michael Montagne

142 ×1.2

GHP

82 ×0.9

17 ×0.3

PHARM

147 ×2.5

196 ×3.5

SPS

Citations per year, relative to Michael Montagne Michael Montagne (= 1×) peers Alan Branthwaite

Countries citing papers authored by Michael Montagne

Since Specialization

Citations

This map shows the geographic impact of Michael Montagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Montagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Montagne more than expected).

Fields of papers citing papers by Michael Montagne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Montagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Montagne. The network helps show where Michael Montagne may publish in the future.

Co-authorship network of co-authors of Michael Montagne

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Montagne. A scholar is included among the top collaborators of Michael Montagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Montagne. Michael Montagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morel, Chloé, Claude Emond, Emilie M. Hardy, et al.. (2023). Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to α-Hexabromocyclododecane. Environmental Toxicology and Pharmacology. 105. 104343–104343. 3 indexed citations

Seoane‐Vazquez, Enrique, et al.. (2021). Effect of free trade agreements on pharmaceutical market competition: The case of the 2009 US-Peru free trade agreement and its implementation as national drug policy. SHILAP Revista de lepidopterología. 2. 100039–100039. 1 indexed citations

Montagne, Michael. (2013). Drugs on the Internet, Part V: Absinthe, Return of the Emerald Mask. Substance Use & Misuse. 48(7). 506–512.

Nguyen, Diane, Enrique Seoane‐Vazquez, Rosa Rodríguez-Monguió, & Michael Montagne. (2013). Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies. BMC Health Services Research. 13(1). 27–27. 6 indexed citations

Montagne, Michael. (2013). Pharmaceutical pictograms: A model for development and testing for comprehension and utility. Research in Social and Administrative Pharmacy. 9(5). 609–620. 65 indexed citations

Montagne, Michael, et al.. (2012). Drugs on the Internet, Part III: Tobacco and Smoking on the Web. Substance Use & Misuse. 48(1-2). 82–88. 5 indexed citations

Montagne, Michael. (2011). Miracle Drug, Poison, or Placebo: Patients’ Experiences With Antidepressant Medications as Described in Postings on an Online Message Board. Substance Use & Misuse. 46(7). 922–930. 3 indexed citations

Montagne, Michael. (2011). Drugs and the Media: An Introduction. Substance Use & Misuse. 46(7). 849–851. 11 indexed citations

Montagne, Michael. (2008). The Medicalization of Everyday Life. Selected Essays.. American Journal of Pharmaceutical Education. 72(5). 62 indexed citations

10.

Montagne, Michael. (2008). Drugs on the Internet. I: Introduction and Web Sites on Psychedelic Drugs. Substance Use & Misuse. 43(1). 17–25. 20 indexed citations

11.

Montagne, Michael. (2004). Social Pharmacology: Integrating Pharmaceutical and Social Science Research on Drug Effects. Drug Information Journal. 38(4). 315–320. 1 indexed citations

12.

Montagne, Michael. (2001). MASS MEDIA REPRESENTATIONS AS DRUG INFORMATION FOR PATIENTS: THE PROZAC PHENOMENON. Substance Use & Misuse. 36(9-10). 1261–1274. 26 indexed citations

13.

Larsson, Sam, et al.. (2001). INTRODUCTION: THE NEED FOR A MULTIDIMENSIONAL AND MULTIDISCIPLINARY APPROACH. Substance Use & Misuse. 36(9-10). 1129–1137. 1 indexed citations

14.

Bleidt, Barry A & Michael Montagne. (1996). Clinical research in pharmaceutical development. 2 indexed citations

15.

Montagne, Michael & David Scott. (1993). Prevention of Substance Use Problems: Models, Factors, and Processes. International Journal of the Addictions. 28(12). 1177–1208. 8 indexed citations

16.

Montagne, Michael, et al.. (1992). Direct-to-Consumer Advertising. Journal of Pharmaceutical Marketing & Management. 6(2). 21–32. 5 indexed citations

17.

Montagne, Michael, et al.. (1992). Drugs, Music, and Ideology: A Social Pharmacological Interpretation of the Acid House Movement. International Journal of the Addictions. 27(10). 1159–1177. 32 indexed citations

18.

Montagne, Michael. (1991). Descriptive Epidemiology of International Cocaine Trafficking. PsycEXTRA Dataset. 110. 275–96. 2 indexed citations

19.

Montagne, Michael. (1990). The Social Epidemiology of International Drug Trafficking: Comparison of Source of Supply and Distribution Networks*. International Journal of the Addictions. 25(5). 557–577. 3 indexed citations

20.

Scott, David, et al.. (1983). The Development and Evaluation of an Interdisciplinary Health Training Program: A Pharmacy Perspective. American Journal of Pharmaceutical Education. 47(1). 42–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact